IRIS PubliCatt

Chiusolo, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.537
EU - Europa 6.112
AS - Asia 2.195
OC - Oceania 150
AF - Africa 85
SA - Sud America 60
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.407
DE - Germania 2.052
SE - Svezia 1.037
IT - Italia 949
CN - Cina 941
SG - Singapore 624
UA - Ucraina 386
GB - Regno Unito 329
IE - Irlanda 312
FR - Francia 302
ID - Indonesia 237
FI - Finlandia 153
RU - Federazione Russa 148
IN - India 145
AU - Australia 130
PL - Polonia 128
CA - Canada 103
TR - Turchia 63
CI - Costa d'Avorio 54
BE - Belgio 46
NL - Olanda 42
JP - Giappone 30
BR - Brasile 29
ES - Italia 28
CZ - Repubblica Ceca 27
HK - Hong Kong 24
IR - Iran 24
AT - Austria 20
NZ - Nuova Zelanda 20
RO - Romania 20
VN - Vietnam 19
MX - Messico 18
HU - Ungheria 17
CH - Svizzera 15
KR - Corea 13
PT - Portogallo 13
TH - Thailandia 13
NO - Norvegia 11
AR - Argentina 10
CL - Cile 10
SA - Arabia Saudita 10
DZ - Algeria 9
EG - Egitto 9
GR - Grecia 9
SK - Slovacchia (Repubblica Slovacca) 9
HR - Croazia 8
IL - Israele 8
EE - Estonia 7
LT - Lituania 7
BG - Bulgaria 6
CO - Colombia 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
BZ - Belize 4
DK - Danimarca 4
EU - Europa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
GH - Ghana 3
MA - Marocco 3
MD - Moldavia 3
MK - Macedonia 3
PE - Perù 3
PH - Filippine 3
QA - Qatar 3
ZA - Sudafrica 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
IQ - Iraq 2
IS - Islanda 2
JO - Giordania 2
LI - Liechtenstein 2
LV - Lettonia 2
UY - Uruguay 2
AZ - Azerbaigian 1
CR - Costa Rica 1
EC - Ecuador 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MC - Monaco 1
MM - Myanmar 1
MT - Malta 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 15.146
Salva come PNG Salva come JPEG
Città #
Chandler 1.057
Singapore 469
Ashburn 454
Dublin 305
Jacksonville 294
Dearborn 243
Jakarta 227
San Mateo 227
Nanjing 178
Milan 174
Ann Arbor 169
Houston 162
Wilmington 158
Beijing 145
Rome 141
Woodbridge 116
New York 114
Nürnberg 114
Fairfield 113
Boston 112
Moscow 109
Redwood City 106
Warsaw 106
Los Angeles 104
Seattle 101
Lancaster 91
Cattolica 89
Munich 88
Nanchang 84
Marseille 81
Princeton 81
Bremen 71
Lawrence 68
Chicago 55
Abidjan 54
Florence 53
Redmond 53
Izmir 49
Boardman 46
Kunming 46
Helsinki 43
Brussels 42
Tianjin 34
Cambridge 33
Shanghai 33
Shenyang 33
Norwalk 32
Guangzhou 31
Toronto 31
Pune 29
Leawood 28
Changsha 27
Hangzhou 27
London 27
San Francisco 27
Sydney 27
Hefei 26
Mountain View 26
Zhengzhou 25
Santa Clara 24
Hebei 23
Melbourne 23
Phoenix 23
Portland 23
Washington 23
Adelaide 22
Auburn Hills 22
Brisbane 22
Brno 22
Jiaxing 21
Hong Kong 19
Lappeenranta 19
Philadelphia 18
Augusta 17
Brooklyn 16
Hanoi 16
San Diego 16
University Park 16
Frankfurt am Main 13
Buffalo 12
Cincinnati 11
Seoul 11
Amsterdam 10
Bangkok 10
Changchun 10
Falls Church 10
Fremont 10
Lanzhou 10
Padova 10
Pittsburgh 10
Tokyo 10
Vienna 10
Atlanta 9
Bologna 9
Cleveland 9
Hermosillo 9
Kansas City 9
Kyoto 9
Mumbai 9
North Hollywood 9
Totale 7.692
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.294
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 355
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 309
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 304
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 228
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 171
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 148
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 148
Correlation between paraproteinaemia and viral reactivation after allo-SCT 142
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 138
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 137
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 133
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 132
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 130
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 128
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 128
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 124
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 123
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 121
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 118
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 116
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 115
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 115
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 115
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 114
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 113
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 111
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 108
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 107
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 105
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 105
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 103
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 103
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 103
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 103
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 102
Hyperleukocytosis and leukostasis: management of a medical emergency 102
Hyperleukocytosis and leukostasis: management of a medical emergency 102
Work related acute leukemia and mucor mycosis in a boat-builder 101
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 101
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 101
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 100
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 99
Neurologic improvement after peripheral blood stem cell transplantation in poems 98
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 98
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 98
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 96
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 96
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 95
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 93
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 92
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 91
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 91
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 88
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 88
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 87
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 87
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 86
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 86
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 86
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 86
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 82
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 81
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 78
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 78
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 77
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 76
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 76
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 75
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 73
Changes in protein serum levels during stem cell transplantation 72
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 71
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 71
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 68
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 68
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 68
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 67
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 67
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 66
Unrelated cord blood transplantation and post-transplant cyclophosphamide 66
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 66
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 65
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 65
Unrelated cord blood transplantation and post-transplant cyclophosphamide 64
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 64
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 64
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 63
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 62
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 62
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 61
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 61
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 60
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 60
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 58
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 58
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 58
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 58
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 57
Totale 12.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.297 0 0 0 0 203 236 199 96 122 166 156 119
2020/20211.252 81 116 81 96 111 101 114 32 151 60 265 44
2021/20221.549 150 91 43 70 104 39 35 219 90 127 261 320
2022/20233.213 435 436 243 475 226 378 182 241 316 89 134 58
2023/20242.666 84 450 125 172 150 302 162 115 105 259 367 375
2024/20251.706 358 271 442 285 350 0 0 0 0 0 0 0
Totale 15.496